Latest
Our John Lukens, PhD, will serve as the inaugural director of the Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases.
Years after his death, some of John Herr's final work could lead to new treatments for breast cancer, melanoma and other solid tumors.
Evan Scott, PhD, comes to UVA from Northwestern, where he has conducted groundbreaking nanotechology research.
“The role of innovation has always been paramount in healthcare, and our 2024 honorees as top Innovators are driving real change in the industry,” said Mary Ellen Podmolik, editor in chief of Modern Healthcare.
Antibodies that act like enzymes may be causing persistent problems for people with long COVID, new research suggests. We may be able to target these "abzymes" to develop better treatments.
There were multiple unsafe sleep practices in more than three-quarters of 7,59 infant deaths reviewed.